Search Results

You searched for : biopharmaceutical  

	Medical Innovations to Watch in 2026: How Technology Is Reshaping Healthcare in India An overview of medical innovations to watch in 2026, covering AI diagnostics, gene therapy, robotics, and India's digital health infrastructure, and their evolving impact ... Jul 10
	Dialogue with HighTide Therapeutics' CMO Dr. Filip Surmont: Moving Beyond the "Blockbuster" Legacy to Reshape Kidney Disease Treatment Through a Dual-Mechanism Approach Across the landscape of global biotech companies, the appointment of a senior executive often serves as a "barometer"—offering insights into a company's pipeline ... Apr 04
	Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint ... Mar 23
	Jubilant Pharmova – Q3 & 9M’FY26 results On track towards Vision 2030 Solid revenue growth of 17% on the back of Line 3 in CDMO sterile Injectables EBITDA margins to expand going ... Feb 06
	BioAsia 2026 to Convene the World’s Leading Science, AI, and Industry Pioneers Driving the TechBio Revolution Global innovators shaping AI-native biology, next-generation medicines and digital-first healthcare to chart the future of global health.... Feb 05
	Post Budget Reaction - HCG Manavata Cancer Centre The Union Budget 2026 marks a significant moment for Indian healthcare. For the first time in the history of independent India, the healthcare allocation has ... Feb 04
	Quote by Mr. Raheel Shah, Business Development Director, BDR Pharmaceuticals ... Feb 02
	HCG Cancer Care, Mumbai | Union Budget 2026 ... Feb 02
	Post-Budget Comment: Union Budget 2026 (Healthcare) ... Feb 02
	Budget Quote - Daanesh H. Nikorawala, Director, F Plus Healthcare Technologies ... Feb 02
	Blockchain in Healthcare Market Size Worth USD 164.89 Billion by 2034 | CAGR: 34.15% The blockchain in healthcare market size is expected to reach USD 164.89 Billion by 2034, according to a new study by Polaris Market Research.... Jan 14
	Insulin Without Pain: Innovation or Illusion for India’s Diabetes Crisis? A small inhaler may seem like a modest innovation, yet its implications reachs outward, touching behavior, psychology, and public health. ... Dec 26
	Bristol Myers Squibb Launches Mosaic: Signals a New Era for Tech-Accelerated Patient Care Demonstrates leadership in AI driven pharma through Accenture partnership.... Dec 16
	Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten Everest Medicines announced on Dec. 11, 2025 that its wholly-owned subsidiary, Everest Medicines (China) Co., Ltd (“Everest Medicines China”), has entered into two strategic ... Dec 15
	HTD1801, a First-in-Class Anti-inflammatory Metabolic Modulator, Demonstrates Durable 52-Week Efficacy and Safety in Two Phase III Trials in Type 2 Diabetes Mellitus These 52-week data reinforce HTD1801's potential as a truly differentiated therapeutic to concurrently address metabolic dysregulation, inflammation, and renal progression in type 2 ... Oct 31
	Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14 Everest Medicines today announced that the first patient has been enrolled in a global multi-center Phase I clinical trial of its Tumor-Associated Antigen ... Oct 15
	Case study: Doctors who became thought leaders in India Indian doctors have long gone beyond clinical practice to influence public health, policy and innovation. Their leadership continues to shape a healthier and more informed ... Oct 09
	AbbVie Hosts National Conclave on World Retina Day to Spotlight Rising Burden of Diabetic Macular Edema Leading Retina Specialists and Endocrinologists unite to emphasize the urgent need for early detection, wider access to treatment, and stronger policy support to address diabetes-... Sep 24
	HighTide Therapeutics Announces Oral Presentation of Phase 3 Data in Patients with Type 2 Diabetes HighTide Therapeutics, Inc. (2511.HK) is an innovative biopharmaceutical company specializing in metabolic diseases.... Sep 17
	Fosun's Bold Innovation & Globalization Drive Valuation Upside In the first half of 2025, Fosun’s four core subsidiaries generated a total revenue of RMB63.61 billion, with their contribution to the Group’... Sep 01
	Everest Medicines Expands Strategic Investment in I-MAB to Advance the Global Value of Its Proprietary Next-Generation Cancer Immunotherapies Everest Medicines today announced a strategic equity investment in I-Mab, under which Everest will invest US$30.9 million in cash.... Aug 05
	Everest Medicines Announces Share Placement to Raise Approximately HK$1,572.50 Million Everest Medicines, together with its controlling shareholder CBC Group and the placing agents, entered into a placing and subscription agreement for the sale of 22,... Jul 28
	CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets China Medical System Holdings Limited on the Main Board of the Singapore Exchange ("SGX"), SGX and CMS co-hosted the "Singapore and Emerging Markets Pharmaceutical ... Jul 22
	HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025 HighTide Therapeutics, a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic liver and metabolic diseases.... Apr 25
	Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA ... Apr 15
25 Matching result(s) found!

Trending Now
	Clinical Interventions in Chronic Hepatitis B and C: Antiviral Efficacy, Liver Fibrosis Scoring, and Monitoring August 11, 2026
	Common Health Mistakes Indians Should Avoid: A Practical Guide to Everyday WellnessAugust 11, 2026
	How to Build a Healthy Lifestyle After 40: A Practical Guide for Indian AdultsAugust 11, 2026
	Milk Microbiome Could Hold New Clues to Lifelong Health, Experts SayAugust 10, 2026
	Globally Renowned Dermatologist and Sesderma Founder Professor Dr. Gabriel Serrano to Visit India to Showcase Cutting-Edge Derma-Tech for Indian Skincare at Scientific Symposiums Hosted by Iberia PharmaceuticalsAugust 10, 2026
	Sharda Hospital Celebrates World Breastfeeding Week with a Week-Long Awareness ProgrammeAugust 10, 2026
	Swinburne University of Technology Opens Applications for Master of Engineering ScienceAugust 10, 2026
	GLP-1 Receptor Agonists: A New Era in Weight Loss TreatmentAugust 10, 2026
	Immunotherapy vs. Chemotherapy: Understanding the Mechanisms of Precision OncologyAugust 10, 2026
	Mitigating Tech-Induced Ailments: Managing Screen Time, Sedentary Lifestyles, and Dry Eye SyndromeAugust 10, 2026
	The Blueprint of Validation: Navigating Medical AI’s "Reckoning Year"August 10, 2026
	The Future of Smart Hospitals: Redefining Healthcare Delivery in India August 10, 2026
	Healthcare Data Security in India: Risks, Threats, and Best Practices for a Digital-First Health EcosystemAugust 10, 2026
	The Science of Resilience: Psychological Strategies for Modern StressAugust 08, 2026
	The Science of Fasting: 2026 Research on Autophagy and LongevityAugust 08, 2026
	Early Markers of Insulin Resistance: Moving Beyond Fasting Blood SugarAugust 08, 2026
	Healthcare Management Challenges in India: What Hospital Leaders Must Address NowAugust 08, 2026
	Importance of Patient Safety: Why Every Hospital in India Must Prioritize ItAugust 08, 2026
	Decoding Fatty Liver Disease: Symptoms, Reversibility, and the MASLD/NAFLD SpectrumAugust 07, 2026
	Heart-Healthy Dietary Patterns: Translating Clinical Nutrition Guidelines into Daily MealsAugust 07, 2026